Vitamin D Treatment in Patients With Chronic Hepatitis C

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2008 by Hillel Yaffe Medical Center.
Recruitment status was  Recruiting
Information provided by:
Hillel Yaffe Medical Center Identifier:
First received: December 7, 2008
Last updated: December 8, 2008
Last verified: December 2008
We hypothesize that patients with Ch.HCV have a low level of vitamin D, and that by raising their vitamin D levels by adding it to their standard treament of Pegylated Interferon and Ribavirin, there will be an increase in their sustained virological response.

Condition Intervention
Chronic Hepatitis C
Drug: Adding vitamin D
Drug: Vitamin D

Study Type: Interventional

Resource links provided by NLM:

Further study details as provided by Hillel Yaffe Medical Center:

Primary Outcome Measures:
  • To increase the sustained virological response [ Time Frame: One year ] [ Designated as safety issue: No ]

Arms Assigned Interventions
Experimental: Vitamin D
An addition of Vitamin D to the standard treatment
Drug: Adding vitamin D
Adding 1000IU/Vitamin D daily
Drug: Vitamin D
Addition of 1000IU/day Vitamin D


Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Chronic Hepatitis C Genotype 1

Exclusion Criteria:

  • Vitamin D intoxication Renal Failure Liver Failure Malignancy
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00804752

Hillel Yaffe Medical Center Recruiting
Hadera, Israel, 38100
Contact: Saif Abu-Mouch, MD   
Principal Investigator: Saif Abu-Mouch, MD         
Sub-Investigator: Jacob Yarchovski, MD         
Sub-Investigator: Carlos Singer, MD         
Sub-Investigator: Abed El-Rauf Zeina, MD         
Sponsors and Collaborators
Hillel Yaffe Medical Center
  More Information

No publications provided

Responsible Party: Dr. Saif Abu-Mouch, Hepatology Clinic, Hillel Yaffe Medical Center Identifier: NCT00804752     History of Changes
Other Study ID Numbers: 0040-08-HYMC 
Study First Received: December 7, 2008
Last Updated: December 8, 2008
Health Authority: Israel: Ministry of Health

Keywords provided by Hillel Yaffe Medical Center:
Patients with Chronic Hepatitis C

Additional relevant MeSH terms:
Hepatitis A
Hepatitis C
Hepatitis C, Chronic
Hepatitis, Chronic
Digestive System Diseases
Enterovirus Infections
Flaviviridae Infections
Hepatitis, Viral, Human
Liver Diseases
Picornaviridae Infections
RNA Virus Infections
Virus Diseases
Vitamin D
Bone Density Conservation Agents
Growth Substances
Pharmacologic Actions
Physiological Effects of Drugs processed this record on February 11, 2016